Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WINDLAS BIOTECH Gains 6%; BSE HEALTHCARE Index Up 2.0%
Fri, 29 Nov 15:51

WINDLAS BIOTECH Gains 6%; BSE HEALTHCARE Index Up 2.0%Image source: StarLineArts/www.istockphoto.com

WINDLAS BIOTECH share price has zoomed 6% and is presently trading at Rs 1,093.1.

Meanwhile, the BSE HEALTHCARE index is at 43,665.5 (up 2.0%).

Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 7.6%) and CAPLIN POINT (up 4.5%).

FDC (down 0.9%) and MAX HEALTHCARE INSTITUTE (down 0.3%) are among the top losers today.

Over the last one year, WINDLAS BIOTECH has moved up from Rs 424.2 to Rs 1,093.1, registering a gain of Rs 668.9 (up 157.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 43,665.5, registering a gain of 47.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 186.6%), SUVEN PHARMACEUTICALS (up 99.2%) and Glenmark Pharma (up 98.2%).

Get savings of Rs 6,050: Join our small cap research service today!

What About the Benchmark Indices?

The BSE Sensex is at 79,802.8 (up 1.0%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 4.4%) and Sun Pharma (up 2.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,123.7 (up 0.9%). Bharti Airtel and Sun Pharma are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 79,802.8, registering a gain of 13,628.6 points (up 20.6%).

WINDLAS BIOTECH Financial Update...

WINDLAS BIOTECH net profit grew 11.6% YoY to Rs 157 million for the quarter ended September 2024, compared to a profit of Rs 140 million a year ago. Net sales rose 22.5% to Rs 1,870 million during the period as against Rs 1,527 million in July-September 2023.

For the year ended March 2024, WINDLAS BIOTECH reported 36.5% increase in net profit to Rs 582 million compared to net profit of Rs 426 million during FY23. Revenue of the company grew 23.0% to Rs 6,310 million during FY24.

The current Price to earnings ratio of WINDLAS BIOTECH, based on rolling 12 month earnings, stands at 37.3.


Equitymaster requests your view! Post a comment on "WINDLAS BIOTECH Gains 6%; BSE HEALTHCARE Index Up 2.0%". Click here!